Utah Retirement Systems’s Ionis Pharmaceuticals IONS Stock Holding History

Utah Retirement Systems’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$623K	Hold	8,300	–	–	0.01%	710
2025 Q4	$657K	Hold	8,300	–	–	0.01%	727
2025 Q3	$543K	Sell	8,300 -100	-1%	-$4.88K	0.01%	737
2025 Q2	$332K	Hold	8,400	–	–	﹤0.01%	851
2025 Q1	$253K	Hold	8,400	–	–	﹤0.01%	895
2024 Q4	$294K	Hold	8,400	–	–	﹤0.01%	891
2024 Q3	$337K	Buy	8,400 +500	+6%	+$23.3K	﹤0.01%	851
2024 Q2	$377K	Hold	7,900	–	–	﹤0.01%	830
2024 Q1	$342K	Hold	7,900	–	–	﹤0.01%	834
2023 Q4	$400K	Buy	7,900 +200	+3%	+$9.58K	0.01%	824
2023 Q3	$349K	Buy	7,700 +200	+3%	+$8.25K	0.01%	832
2023 Q2	$308K	Hold	7,500	–	–	﹤0.01%	891
2023 Q1	$268K	Hold	7,500	–	–	﹤0.01%	884
2022 Q4	$283K	Hold	7,500	–	–	﹤0.01%	878
2022 Q3	$332K	Buy	7,500 +100	+1%	+$4.21K	0.01%	849
2022 Q2	$274K	Hold	7,400	–	–	﹤0.01%	901
2022 Q1	$274K	Sell	7,400 -18,009	-71%	-$589K	﹤0.01%	912
2021 Q4	$773K	Buy	25,409 +100	+0.4%	+$3.15K	0.01%	816
2021 Q3	$849K	Sell	25,309 -1,400	-5%	-$52.8K	0.01%	810
2021 Q2	$1.06M	Buy	26,709 +1,600	+6%	+$62.7K	0.01%	779
2021 Q1	$1.13M	Sell	25,109 -1,100	-4%	-$61.3K	0.02%	752
2020 Q4	$1.48M	Buy	26,209 +1,200	+5%	+$59.8K	0.02%	636
2020 Q3	$1.19M	Buy	25,009 +100	+0.4%	+$5.55K	0.02%	640
2020 Q2	$1.47M	Buy	24,909 +500	+2%	+$27.8K	0.03%	539
2020 Q1	$1.15M	Hold	24,409	–	–	0.03%	549
2019 Q4	$1.47M	Buy	24,409 +100	+0.4%	+$5.96K	0.03%	599
2019 Q3	$1.46M	Buy	24,309 +300	+1%	+$19.6K	0.03%	583
2019 Q2	$1.54M	Buy	24,009 +429	+2%	+$30.3K	0.03%	562
2019 Q1	$1.91M	Buy	23,580 +280	+1%	+$18.1K	0.04%	465
2018 Q4	$1.26M	Buy	23,300 +100	+0.4%	+$5.1K	0.03%	563
2018 Q3	$1.2M	Buy	23,200 +100	+0.4%	+$4.7K	0.02%	647
2018 Q2	$963K	Buy	23,100 +100	+0.4%	+$4.43K	0.02%	751
2018 Q1	$1.01M	Hold	23,000	–	–	0.02%	701
2017 Q4	$1.16M	Buy	23,000 +400	+2%	+$21.9K	0.02%	646
2017 Q3	$1.15M	Hold	22,600	–	–	0.03%	625
2017 Q2	$1.15M	Buy	22,600 +600	+3%	+$27.9K	0.03%	612
2017 Q1	$884K	Buy	22,000 +100	+0.5%	+$4.49K	0.02%	706
2016 Q4	$1.05M	Hold	21,900	–	–	0.03%	623
2016 Q3	$803K	Hold	21,900	–	–	0.02%	712
2016 Q2	$510K	Buy	21,900 +500	+2%	+$16.1K	0.01%	860
2016 Q1	$866K	Hold	21,400	–	–	0.02%	664
2015 Q4	$1.32M	Hold	21,400	–	–	0.04%	504
2015 Q3	$865K	Buy	21,400 +100	+0.5%	+$5.18K	0.02%	664
2015 Q2	$1.23M	Buy	+21,300	New	+$1.35M	0.03%	569

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Utah Retirement Systems's IONS Position: Q1 2026 in Review

Utah Retirement Systems held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 8,300 shares worth $623K. The position accounts for 0.01% of the portfolio, ranked #710.

Utah Retirement Systems first reported a position in IONS in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.91M in Q1 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Utah Retirement Systems held 8,300 shares of Ionis Pharmaceuticals worth $623K as of Q1 2026.
Utah Retirement Systems left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
Ionis Pharmaceuticals made up 0.01% of Utah Retirement Systems's portfolio in Q1 2026, its #710 holding.
Utah Retirement Systems first reported a position in Ionis Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
Utah Retirement Systems's Ionis Pharmaceuticals position peaked at $1.91M in Q1 2019.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Utah Retirement Systems's 13F filing for Q1 2026, filed 15 May 2026.